Editorial: Are we facing an efficacy–effectiveness gap in pediatric psychopharmacology?
Journal of Child Psychology and Psychiatry · 2026-12 · 67 (12) · 1933-1936
DOI: 10.1111/jcpp.70252 ↗At a glance
Editorial in Journal of Child Psychology and Psychiatry, published online on 2026-10-28. Written by Michael H Bloch. Institution: Yale Child Study Center, Yale School of Medicine, New Haven, Connecticut, USA. Major MEDLINE topics: Psychopharmacology, Mental Disorders, Pediatrics. 18 references. Funded by: NeuroThera Labs, Emalex Biosciences, Janssen Pharmaceuticals.
Abstract (original language)
The efficacy–effectiveness gap, the attenuation of benefits as interventions move from controlled trials into routine care, has received substantial focus when scrutinizing psychological interventions but has received less attention in pediatric psychopharmacology. Medication trials evaluate more than molecules: they embed systematic titration, frequent assessment, multi‐informant feedback, and adherence support. This Editorial examines whether differences between trial‐based and routine medication management create a comparable gap. Examples from stimulant treatment in the MTA, antidepressant protocols in TADS and TORDIA, and metabolic surveillance during antipsychotic treatment illustrate how dosing, follow‐up, and safety monitoring may diverge in practice, potentially altering both efficacy and the overall benefit–risk balance. Research should characterize how medications are delivered in routine care and identify which elements of trial‐based management materially improve outcomes. Disseminating evidence‐based pediatric psychopharmacology may require preserving essential medication‐management processes while recognizing constraints faced in practice.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Yale Child Study Center, Yale School of Medicine, New Haven, Connecticut, USA.
ORCID profiles: Michael H Bloch
Funding
- NeuroThera Labs
- Emalex Biosciences
- Janssen Pharmaceuticals
- Neurocrine Biosciences
- NIH HHS
- Janssen Pharmaceutica
- National Institutes of Health
Cite
APA
Bloch, M. H. (2026). Editorial: Are we facing an efficacy–effectiveness gap in pediatric psychopharmacology?. Journal of Child Psychology and Psychiatry, 67(12), 1933-1936. https://doi.org/10.1111/jcpp.70252
Vancouver
Bloch MH. Editorial: Are we facing an efficacy–effectiveness gap in pediatric psychopharmacology?. Journal of Child Psychology and Psychiatry. 2026;67(12):1933-1936. doi:10.1111/jcpp.70252
BibTeX
@article{Bloch2026,
author = {Bloch, Michael H},
title = {Editorial: Are we facing an efficacy–effectiveness gap in pediatric psychopharmacology?},
journal = {Journal of Child Psychology and Psychiatry},
year = {2026},
volume = {67},
number = {12},
pages = {1933--1936},
doi = {10.1111/jcpp.70252}
}
EUVIMED